Protagonist Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 9.78 M | $1.03 B | 0.65% | 15.38% |
| FARALLON CAPITAL MANAGEMENT LLC | 05/15/2026 | 6.35 M | $669.17 M | 3.34% | 9.99% |
| UBS GROUP AG | 05/05/2026 | 5.18 M | $545.74 M | 86.92% | 8.14% |
| RTW INVESTMENTS, LP | 05/15/2026 | 5.06 M | $533.22 M | 0.00% | 7.96% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 3.60 M | $379.40 M | 13.50% | 5.66% |
| 05/15/2026 | 3.48 M | $366.92 M | 100.00% | 5.48% | |
| STATE STREET CORP | 05/15/2026 | 3.12 M | $328.51 M | -2.59% | 4.90% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 2.89 M | $304.87 M | 9.12% | 4.55% |
| 05/15/2026 | 2.81 M | $295.74 M | 100.00% | 4.41% | |
| JOHNSON & JOHNSON | 05/13/2026 | 2.45 M | $258.14 M | 0.00% | 3.85% |
| INVESCO LTD. | 05/12/2026 | 2.16 M | $228.16 M | 38.07% | 3.41% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.67 M | $175.98 M | 14.90% | 2.63% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 1.67 M | $175.55 M | 18.90% | 2.62% |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.55 M | $163.57 M | 37.74% | 2.44% |
| WOODLINE PARTNERS LP | 05/15/2026 | 1.41 M | $149.05 M | 0.38% | 2.22% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 1.30 M | $136.54 M | 49.32% | 2.04% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 1.23 M | $129.73 M | -8.85% | 1.94% |
| JENNISON ASSOCIATES LLC | 05/06/2026 | 1.07 M | $112.99 M | 223.71% | 1.69% |
| MORGAN STANLEY | 05/15/2026 | 1.02 M | $107.32 M | 15.84% | 1.60% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 994.12 K | $104.78 M | -5.25% | 1.56% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 05/15/2026 | 829.29 K | $87.41 M | 100.00% | 1.30% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 778.95 K | $82.10 M | -18.96% | 1.23% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2026 | 720.93 K | $75.99 M | -34.41% | 1.13% |
| FMR LLC | 05/15/2026 | 662.00 K | $69.77 M | 22.62% | 1.04% |
| MARSHALL WACE, LLP | 05/15/2026 | 628.08 K | $66.20 M | -38.72% | 0.99% |
| CLEARBRIDGE INVESTMENTS, LLC | 05/13/2026 | 621.82 K | $65.54 M | 26.94% | 0.98% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2026 | 593.20 K | $62.52 M | 197.31% | 0.93% |
| NORTHERN TRUST CORP | 05/14/2026 | 587.97 K | $61.97 M | 2.23% | 0.92% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 581.08 K | $61.25 M | 9.71% | 0.91% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 05/12/2026 | 571.83 K | $60.27 M | 0.00% | 0.90% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 552.96 K | $58.28 M | -0.68% | 0.87% |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 537.32 K | $56.63 M | 0.35% | 0.85% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 508.10 K | $53.54 M | 22.61% | 0.80% |
| VOYA INVESTMENT MANAGEMENT LLC | 05/12/2026 | 454.38 K | $47.89 M | 24.09% | 0.71% |
| RUBRIC CAPITAL MANAGEMENT LP | 05/15/2026 | 428.00 K | $45.11 M | 100.00% | 0.67% |
| VANGUARD FIDUCIARY TRUST CO | 05/15/2026 | 412.73 K | $43.50 M | 100.00% | 0.65% |
| PRINCIPAL FINANCIAL GROUP INC | 05/04/2026 | 367.82 K | $38.77 M | 5.72% | 0.58% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2026 | 355.00 K | $37.42 M | -6.74% | 0.56% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 341.47 K | $35.99 M | -2.55% | 0.54% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 326.16 K | $34.38 M | 100.00% | 0.51% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2026 | 306.04 K | $32.26 M | -7.49% | 0.48% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 282.44 K | $29.77 M | 21.30% | 0.44% |
| 05/07/2026 | 232.42 K | $24.50 M | 100.00% | 0.37% | |
| 05/14/2026 | 229.62 K | $24.20 M | 0.00% | 0.36% | |
| SEGALL BRYANT & HAMILL, LLC | 05/22/2026 | 212.71 K | $22.42 M | 64.82% | 0.33% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 05/13/2026 | 210.28 K | $22.16 M | 3.37% | 0.33% |
| HOLOCENE ADVISORS, LP | 05/15/2026 | 209.92 K | $22.13 M | -0.05% | 0.33% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 194.53 K | $20.50 M | 98.98% | 0.31% |
| TD ASSET MANAGEMENT INC | 05/11/2026 | 183.70 K | $19.36 M | 15.73% | 0.29% |
| EAGLE HEALTH INVESTMENTS LP | 05/15/2026 | 179.32 K | $18.90 M | 212.95% | 0.28% |
Protagonist Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 394 institutional investors and hedge funds held shares of Protagonist Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 9.78 M
FARALLON CAPITAL MANAGEMENT LLC: 6.35 M
UBS Group AG: 5.18 M
RTW INVESTMENTS, LP: 5.06 M
WELLINGTON MANAGEMENT GROUP LLP: 3.6 M
STATE STREET CORP: 3.12 M
123.87% of Protagonist Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 88.71 M shares in the last 24 months. This purchase volume represents approximately $8.58 B in transactions.